It was a busy and inspiring day for Occuity — welcoming Beth White from the Office for Life Sciences to our Reading HQ before heading to Lancaster House for a celebration of UK–India relations. A proud moment to reflect on how far we’ve come and the global impact our innovation can have.

As Occuity opens its latest crowdfunding round on Republic Europe, we spoke with existing investor Chris Gibbs about what drew him to support the company and how he sees its potential. “I love the tech. The science nerd in me thinks it is very cool.” Chris Gibbs, Occuity Shareholder Chris works as a freelance consultant in medical device product development and has previously held roles across R&D in a range of MedTech companies, from start-ups to global businesses. He holds

At Occuity, our mission is to create elegant, non-contact optical devices that bring advanced diagnostic capabilities into everyday healthcare settings. To achieve this, we invest deeply in research and development, pioneering new approaches in optical engineering. Central to this work is our intellectual property, which protects the originality of our technology and supports our global expansion. Occuity is a very innovative company with a very talented team of engineers, an

Occuity CEO, Dr. Dan Daly joins UK Prime Minister Sir Keir Starmer on the official UK Government Trade Delegation to India